Relative biological effectiveness of clinically relevant photon energies for the survival of human colorectal, cervical, and prostate cancer cell lines

<i>Objective.</i>Relative biological effectiveness (RBE) differs between radiation qualities. However, an RBE of 1.0 has been established for photons regardless of the wide range of photon energies used clinically, the lack of reproducibility in radiobiological studies, and outdated reference energies used in the experimental literature. Moreover, due to intrinsic radiosensitivity, different cancer types have different responses to radiation. This study aimed to characterize the RBE of clinically relevant high and low photon energies<i>in vitro</i>for three human cancer cell lines: HCT116 (colon), HeLa (cervix), and PC3 (prostate).<i>Approach.</i>Experiments were conducted following dosimetry protocols provided by the American Association of Physicists in Medicine. Cells were irradiated with 6 MV x-rays, an<sup>192</sup>Ir brachytherapy source, 225 kVp and 50 kVp x-rays. Cell survival post-irradiation was assessed using the clonogenic assay. Survival fractions were fitted using the linear quadratic model, and survival curves were generated for RBE calculations.<i>Main results.</i>Cell killing was more efficient with decreasing photon energy. Using 225 kVp x-rays as the reference, the HCT116 RBE<sub>SF0.1</sub>for 6 MV x-rays,<sup>192</sup>Ir, and 50 kVp x-rays were 0.89 ± 0.03, 0.95 ± 0.03, and 1.24 ± 0.04; the HeLa RBE<sub>SF0.1</sub>were 0.95 ± 0.04, 0.97 ± 0.05, and 1.09 ± 0.03, and the PC3 RBE<sub>SF0.1</sub>were 0.84 ± 0.01, 0.84 ± 0.01, and 1.13 ± 0.02, respectively. HeLa and PC3 cells had varying radiosensitivity when irradiated with 225 and 50 kVp x-rays.<i>Significance.</i>This difference supports the notion that RBE may not be 1.0 for all photons through experimental investigations that employed precise dosimetry. It highlights that different cancer types may not have identical responses to the same irradiation quality. Additionally, the RBE of clinically relevant photons was updated to the reference energy of 225 kVp x-rays.

Authors

Institutions

Publication Details

Journal
Physics in Medicine and Biology
Published
2024-09-19
DOI
https://doi.org/10.1088/1361-6560/ad7d5a
Citations
7
Primary Topic
Advanced Radiotherapy Techniques
Type
article
Field-Weighted Citation Impact
4.25

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relative biological effectiveness of clinically relevant photon energies for the survival of human colorectal, cervical, and prostate cancer cell lines

Michael D. Evans, T. Vuong, Shirin Abbasinejad Enger, Tanner Connell et al.
7 citations
Physics in Medicine and Biology
Advanced Radiotherapy Techniques
4.25
article

Relative biological effectiveness of clinically relevant photon energies for the survival of human colorectal, cervical, and prostate cancer cell lines

Michael D. Evans, T. Vuong, Shirin Abbasinejad Enger, Tanner Connell, Joanna Li, Naim Chabaytah, Behnaz Behmand, Hamed Bekerat, R. Ruo, Joud Babik
article en
7 citations

Abstract

<i>Objective.</i>Relative biological effectiveness (RBE) differs between radiation qualities. However, an RBE of 1.0 has been established for photons regardless of the wide range of photon energies used clinically, the lack of reproducibility in radiobiological studies, and outdated reference energies used in the experimental literature. Moreover, due to intrinsic radiosensitivity, different cancer types have different responses to radiation. This study aimed to characterize the RBE of clinically relevant high and low photon energies<i>in vitro</i>for three human cancer cell lines: HCT116 (colon), HeLa (cervix), and PC3 (prostate).<i>Approach.</i>Experiments were conducted following dosimetry protocols provided by the American Association of Physicists in Medicine. Cells were irradiated with 6 MV x-rays, an<sup>192</sup>Ir brachytherapy source, 225 kVp and 50 kVp x-rays. Cell survival post-irradiation was assessed using the clonogenic assay. Survival fractions were fitted using the linear quadratic model, and survival curves were generated for RBE calculations.<i>Main results.</i>Cell killing was more efficient with decreasing photon energy. Using 225 kVp x-rays as the reference, the HCT116 RBE<sub>SF0.1</sub>for 6 MV x-rays,<sup>192</sup>Ir, and 50 kVp x-rays were 0.89 ± 0.03, 0.95 ± 0.03, and 1.24 ± 0.04; the HeLa RBE<sub>SF0.1</sub>were 0.95 ± 0.04, 0.97 ± 0.05, and 1.09 ± 0.03, and the PC3 RBE<sub>SF0.1</sub>were 0.84 ± 0.01, 0.84 ± 0.01, and 1.13 ± 0.02, respectively. HeLa and PC3 cells had varying radiosensitivity when irradiated with 225 and 50 kVp x-rays.<i>Significance.</i>This difference supports the notion that RBE may not be 1.0 for all photons through experimental investigations that employed precise dosimetry. It highlights that different cancer types may not have identical responses to the same irradiation quality. Additionally, the RBE of clinically relevant photons was updated to the reference energy of 225 kVp x-rays.

Physics in Medicine and BiologyVol. 69(20)
McGill University Health Centre (CA), Jewish General Hospital (CA), McGill University (CA)
Natural Sciences and Engineering Research Council of Canada
Openalex Percentile: Top 5%
Advanced Radiotherapy Techniques
4.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.